The global High Throughput Screening (HTS) Service market is projected to grow from US$ 308.64 million in 2024 to US$ 550.23 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.12% during the forecast period.
The US & Canada market for High Throughput Screening (HTS) Service is estimated to increase from $ 142.04 million in 2024 to reach $ 250.02 million by 2030, at a CAGR of 9.88% during the forecast period of 2024 through 2030.
The China market for High Throughput Screening (HTS) Service is estimated to increase from $ 60.32 million in 2024 to reach $ 122.40 million by 2030, at a CAGR of 12.52% during the forecast period of 2024 through 2030.
The Europe market for High Throughput Screening (HTS) Service is estimated to increase from $ 46.57 million in 2024 to reach $ 77.96 million by 2030, at a CAGR of 8.97% during the forecast period of 2024 through 2030.
The global key companies of High Throughput Screening (HTS) Service include Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, and Bienta (Enamine), etc. In 2023, the global top five players had a share approximately 32.58% in terms of revenue.
Report Includes
This report presents an overview of global market for High Throughput Screening (HTS) Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of High Throughput Screening (HTS) Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for High Throughput Screening (HTS) Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Turkey, Saudi Arabia, and Other Countries.
This report focuses on the High Throughput Screening (HTS) Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global High Throughput Screening (HTS) Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for High Throughput Screening (HTS) Service revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, and Bienta (Enamine), etc.
麻豆原创 Segmentation
By Company
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience
Segment by Type
Chemical-based HTS Service
Biological-based HTS Service
Cell-based HTS Service
Genetic-based HTS Service
Segment by Application
Pharmaceutical & Biotechnology Companies
Universities & Scientific Research Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of High Throughput Screening (HTS) Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Throughput Screening (HTS) Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, High Throughput Screening (HTS) Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview 1
1.1 Study Scope 1
1.2 麻豆原创 Analysis by Type 1
1.2.1 Global High Throughput Screening (HTS) Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030 1
1.2.2 Chemical-based HTS Service 3
1.2.3 Biological-based HTS Service 4
1.2.4 Cell-based HTS Service 6
1.2.5 Genetic-based HTS Service 7
1.3 麻豆原创 by Application 9
1.3.1 Global High Throughput Screening (HTS) Service 麻豆原创 Share by Application: 2019 VS 2023 VS 2030 9
1.3.2 Pharmaceutical & Biotechnology Companies 10
1.3.3 Universities & Scientific Research Institutions 10
1.4 Assumptions and Limitations 11
1.5 Study Objectives 12
1.6 Years Considered 12
2 Global Growth Trends 13
2.1 Global High Throughput Screening (HTS) Service 麻豆原创 Perspective (2019-2030) 13
2.2 Global High Throughput Screening (HTS) Service Growth Trends by Region 14
2.2.1 Global High Throughput Screening (HTS) Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030 15
2.2.2 High Throughput Screening (HTS) Service Historic 麻豆原创 Size by Region (2019-2024) 16
2.2.3 High Throughput Screening (HTS) Service Forecasted 麻豆原创 Size by Region (2025-2030) 17
2.3 High Throughput Screening (HTS) Service 麻豆原创 Dynamics 18
2.3.1 High Throughput Screening (HTS) Service Industry Trends 18
2.3.2 High Throughput Screening (HTS) Service 麻豆原创 Drivers 19
2.3.3 High Throughput Screening (HTS) Service 麻豆原创 Challenges 20
2.3.4 High Throughput Screening (HTS) Service 麻豆原创 Restraints 21
3 Competition Landscape by Key Players 22
3.1 Global Revenue High Throughput Screening (HTS) Service by Players 22
3.1.1 Global High Throughput Screening (HTS) Service Revenue by Players (2019-2024) 22
3.1.2 Global High Throughput Screening (HTS) Service Revenue 麻豆原创 Share by Players (2019-2024) 23
3.2 Global High Throughput Screening (HTS) Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3) 25
3.3 Global Key Players of High Throughput Screening (HTS) Service, Ranking by Revenue, 2022 VS 2023 VS 2024 26
3.4 Global High Throughput Screening (HTS) Service 麻豆原创 Concentration Ratio 28
3.4.1 Global High Throughput Screening (HTS) Service 麻豆原创 Concentration Ratio (CR5 and HHI) 28
3.4.2 Global Top 10 and Top 5 Companies by High Throughput Screening (HTS) Service Revenue in 2023 29
3.5 Global Key Players of High Throughput Screening (HTS) Service Head office and Area Served 30
3.6 Global Key Players of High Throughput Screening (HTS) Service, Product and Application 31
3.7 Global Key Players of High Throughput Screening (HTS) Service, Date of Enter into This Industry 33
3.8 Mergers & Acquisitions, Expansion Plans 34
4 High Throughput Screening (HTS) Service Breakdown Data by Type 36
4.1 Global High Throughput Screening (HTS) Service Historic 麻豆原创 Size by Type (2019-2024) 36
4.2 Global High Throughput Screening (HTS) Service Forecasted 麻豆原创 Size by Type (2025-2030) 37
5 High Throughput Screening (HTS) Service Breakdown Data by Application 38
5.1 Global High Throughput Screening (HTS) Service Historic 麻豆原创 Size by Application (2019-2024) 38
5.2 Global High Throughput Screening (HTS) Service Forecasted 麻豆原创 Size by Application (2025-2030) 39
6 North America 40
6.1 North America High Throughput Screening (HTS) Service 麻豆原创 Size (2019-2030) 40
6.2 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Type 41
6.2.1 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2019-2024) 41
6.2.2 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2025-2030) 41
6.3 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Application 42
6.3.1 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2019-2024) 42
6.3.2 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2025-2030) 42
6.4 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Country 43
6.4.1 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030 43
6.4.2 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Country (2019-2024) 43
6.4.3 North America High Throughput Screening (HTS) Service 麻豆原创 Share by Country (2025-2030) 44
6.4.4 United States 44
6.4.5 Canada 45
7 Europe 46
7.1 Europe High Throughput Screening (HTS) Service 麻豆原创 Size (2019-2030) 46
7.2 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Type 47
7.2.1 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2019-2024) 47
7.2.2 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2025-2030) 47
7.3 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Application 48
7.3.1 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2019-2024) 48
7.3.2 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2025-2030) 48
7.4 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Country 49
7.4.1 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030 49
7.4.2 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Country (2019-2024) 49
7.4.3 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Country (2025-2030) 50
7.4.4 Germany 51
7.4.5 France 51
7.4.6 U.K. 52
7.4.7 Italy 52
7.4.8 Russia 53
8 China 54
8.1 China High Throughput Screening (HTS) Service 麻豆原创 Size (2019-2030) 54
8.2 China High Throughput Screening (HTS) Service 麻豆原创 Size by Type 55
8.2.1 China High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2019-2024) 55
8.2.2 China High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2025-2030) 55
8.3 China High Throughput Screening (HTS) Service 麻豆原创 Size by Application 56
8.3.1 China High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2019-2024) 56
8.3.2 China High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2025-2030) 56
9 Asia (excluding China) 57
9.1 Asia High Throughput Screening (HTS) Service 麻豆原创 Size (2019-2030) 57
9.2 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Type 58
9.2.1 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2019-2024) 58
9.2.2 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2025-2030) 58
9.3 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Application 59
9.3.1 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2019-2024) 59
9.3.2 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2025-2030) 59
9.4 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Region 60
9.4.1 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030 60
9.4.2 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Region (2019-2024) 60
9.4.3 Asia High Throughput Screening (HTS) Service 麻豆原创 Size by Region (2025-2030) 61
9.4.4 Japan 62
9.4.5 South Korea 62
9.4.6 China Taiwan 63
9.4.7 Southeast Asia 63
9.4.8 India 64
9.4.9 Australia 64
10 Middle East, Africa, and Latin America 65
10.1 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size (2019-2030) 65
10.2 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Type 66
10.2.1 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2019-2024) 66
10.2.2 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Type (2025-2030) 66
10.3 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Application 67
10.3.1 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2019-2024) 67
10.3.2 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2025-2030) 67
10.4 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Country 68
10.4.1 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030 68
10.4.2 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Country (2019-2024) 69
10.4.3 Middle East, Africa, and Latin America High Throughput Screening (HTS) Service 麻豆原创 Size by Country (2025-2030) 69
10.4.4 Brazil 70
10.4.5 Mexico 70
10.4.6 Turkey 71
10.4.7 Saudi Arabia 71
11 Key Players Profiles 72
11.1 Eurofins Discovery 72
11.1.1 Eurofins Discovery Company Details 72
11.1.2 Eurofins Discovery Business Overview 72
11.1.3 Eurofins Discovery High Throughput Screening (HTS) Service Introduction 73
11.1.4 Eurofins Discovery Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 74
11.1.5 Eurofins Discovery Recent Development 74
11.2 Charles River Laboratories 75
11.2.1 Charles River Laboratories Company Details 75
11.2.2 Charles River Laboratories Business Overview 75
11.2.3 Charles River Laboratories High Throughput Screening (HTS) Service Introduction 76
11.2.4 Charles River Laboratories Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 76
11.2.5 Charles River Laboratories Recent Development 77
11.3 Axcelead 78
11.3.1 Axcelead Company Details 78
11.3.2 Axcelead Business Overview 78
11.3.3 Axcelead High Throughput Screening (HTS) Service Introduction 79
11.3.4 Axcelead Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 80
11.3.5 Axcelead Recent Development 80
11.4 NUVISAN 81
11.4.1 NUVISAN Company Details 81
11.4.2 NUVISAN Business Overview 81
11.4.3 NUVISAN High Throughput Screening (HTS) Service Introduction 82
11.4.4 NUVISAN Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 82
11.4.5 NUVISAN Recent Development 82
11.5 Axxam S.p.A. 83
11.5.1 Axxam S.p.A. Company Details 83
11.5.2 Axxam S.p.A. Business Overview 83
11.5.3 Axxam S.p.A. High Throughput Screening (HTS) Service Introduction 84
11.5.4 Axxam S.p.A. Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 84
11.5.5 Axxam S.p.A. Recent Development 85
11.6 Evotec 85
11.6.1 Evotec Company Details 85
11.6.2 Evotec Business Overview 86
11.6.3 Evotec High Throughput Screening (HTS) Service Introduction 86
11.6.4 Evotec Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 87
11.6.5 Evotec Recent Development 87
11.7 Selvita 88
11.7.1 Selvita Company Details 88
11.7.2 Selvita Business Overview 88
11.7.3 Selvita High Throughput Screening (HTS) Service Introduction 89
11.7.4 Selvita Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 90
11.7.5 Selvita Recent Development 90
11.8 Azenta Life Sciences 91
11.8.1 Azenta Life Sciences Company Details 91
11.8.2 Azenta Life Sciences Business Overview 91
11.8.3 Azenta Life Sciences High Throughput Screening (HTS) Service Introduction 92
11.8.4 Azenta Life Sciences Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 92
11.8.5 Azenta Life Sciences Recent Development 93
11.9 Bienta (Enamine) 93
11.9.1 Bienta (Enamine) Company Details 93
11.9.2 Bienta (Enamine) Business Overview 94
11.9.3 Bienta (Enamine) High Throughput Screening (HTS) Service Introduction 94
11.9.4 Bienta (Enamine) Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 95
11.9.5 Bienta (Enamine) Recent Development 95
11.10 Cayman Chemical 96
11.10.1 Cayman Chemical Company Details 96
11.10.2 Cayman Chemical Business Overview 96
11.10.3 Cayman Chemical High Throughput Screening (HTS) Service Introduction 97
11.10.4 Cayman Chemical Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 97
11.10.5 Cayman Chemical Recent Development 98
11.11 Creative Biolabs 98
11.11.1 Creative Biolabs Company Details 98
11.11.2 Creative Biolabs Business Overview 99
11.11.3 Creative Biolabs High Throughput Screening (HTS) Service Introduction 99
11.11.4 Creative Biolabs Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 100
11.12 Creative Bioarray 100
11.12.1 Creative Bioarray Company Details 100
11.12.2 Creative Bioarray Business Overview 101
11.12.3 Creative Bioarray High Throughput Screening (HTS) Service Introduction 101
11.12.4 Creative Bioarray Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 102
11.13 BOC Sciences 102
11.13.1 BOC Sciences Company Details 102
11.13.2 BOC Sciences Business Overview 103
11.13.3 BOC Sciences High Throughput Screening (HTS) Service Introduction 103
11.13.4 BOC Sciences Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 104
11.14 MEDICILON 104
11.14.1 MEDICILON Company Details 104
11.14.2 MEDICILON Business Overview 105
11.14.3 MEDICILON High Throughput Screening (HTS) Service Introduction 105
11.14.4 MEDICILON Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 106
11.14.5 MEDICILON Recent Development 106
11.15 Domainex 107
11.15.1 Domainex Company Details 107
11.15.2 Domainex Business Overview 107
11.15.3 Domainex High Throughput Screening (HTS) Service Introduction 108
11.15.4 Domainex Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 108
11.15.5 Domainex Recent Development 109
11.16 Creative Diagnostics 109
11.16.1 Creative Diagnostics Company Details 109
11.16.2 Creative Diagnostics Business Overview 110
11.16.3 Creative Diagnostics High Throughput Screening (HTS) Service Introduction 110
11.16.4 Creative Diagnostics Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 111
11.17 Multispan 111
11.17.1 Multispan Company Details 111
11.17.2 Multispan Business Overview 112
11.17.3 Multispan High Throughput Screening (HTS) Service Introduction 112
11.17.4 Multispan Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 113
11.18 AntalGenics 113
11.18.1 AntalGenics Company Details 113
11.18.2 AntalGenics Business Overview 114
11.18.3 AntalGenics High Throughput Screening (HTS) Service Introduction 114
11.18.4 AntalGenics Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 115
11.19 Creative Biostructure 115
11.19.1 Creative Biostructure Company Details 115
11.19.2 Creative Biostructure Business Overview 116
11.19.3 Creative Biostructure High Throughput Screening (HTS) Service Introduction 117
11.19.4 Creative Biostructure Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 118
11.20 BPS Bioscience 118
11.20.1 BPS Bioscience Company Details 118
11.20.2 BPS Bioscience Business Overview 119
11.20.3 BPS Bioscience High Throughput Screening (HTS) Service Introduction 119
11.20.4 BPS Bioscience Revenue in High Throughput Screening (HTS) Service Business (2019-2024) 120
11.20.5 BPS Bioscience Recent Development 120
12 Analyst's Viewpoints/Conclusions 121
13 Appendix 122
13.1 Research Methodology 122
13.1.1 Methodology/Research Approach 122
13.1.2 Data Source 125
13.2 Author Details 128
13.3 Disclaimer 129
閳�
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience
听
听
*If Applicable.
